We are live on ! Find out more
KLI

Kelman-Lazarov Inc Portfolio holdings

AUM $763M
1-Year Est. Return 17.15%
This Fund
S&P 500
This Quarter Est. Return
+2.11%
1 Year Est. Return
+17.15%
3 Year Est. Return
+46.63%
5 Year Est. Return
+46.08%
10 Year Est. Return
+173.66%
AUM
$700M
AUM Growth
+$25.8M
Cap. Flow
+$12.3M
Cap. Flow %
1.76%
Top 10 Hldgs %
53.89%
Holding
137
New
5
Increased
78
Reduced
36
Closed
3

Sector Composition

Rank Sector Weight
1 Financials 3.22%
2 Technology 1.18%
3 Communication Services 1.01%
4 Consumer Discretionary 0.56%
5 Consumer Staples 0.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVDV icon
76
Avantis International Small Cap Value ETF
AVDV
$19.7B
$728K 0.1%
7,748
+2,146
+38% +$195K
FNDF icon
77
Schwab Fundamental International Large Company Index ETF
FNDF
$25.5B
$728K 0.1%
16,102
-28
-0.2% -$1.24K
IVE icon
78
iShares S&P 500 Value ETF
IVE
$50B
$725K 0.1%
3,419
-364
-10% -$76.3K
NUBD icon
79
Nuveen ESG US Aggregate Bond ETF
NUBD
$464M
$680K 0.1%
30,429
+570
+2% +$12.8K
JNJ icon
80
Johnson & Johnson
JNJ
$631B
$680K 0.1%
3,283
+31
+1% +$6.13K
QQQ icon
81
Invesco QQQ Trust
QQQ
$479B
$668K 0.1%
1,088
+315
+41% +$193K
AVGO icon
82
Broadcom
AVGO
$2.01T
$658K 0.09%
1,901
+1,056
+125% +$378K
AXP icon
83
American Express
AXP
$229B
$647K 0.09%
1,750
-73
-4% -$26.1K
VB icon
84
Vanguard Morningstar Small-Cap ETF
VB
$82.5B
$615K 0.09%
2,383
EFG icon
85
iShares MSCI EAFE Growth ETF
EFG
$17.2B
$603K 0.09%
5,295
IBB icon
86
iShares Biotechnology ETF
IBB
$9.82B
$573K 0.08%
3,394
+1
+0% +$162
GBIL icon
87
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$7.59B
$528K 0.08%
5,283
-1,196
-18% -$120K
GEM icon
88
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.7B
$508K 0.07%
12,200
-763
-6% -$31.8K
SPTM icon
89
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14.1B
$502K 0.07%
6,086
+3
+0% +$245
SCHZ icon
90
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
$487K 0.07%
20,845
+274
+1% +$6.43K
PEP icon
91
PepsiCo
PEP
$188B
$481K 0.07%
3,352
-1,740
-34% -$256K
PM icon
92
Philip Morris
PM
$290B
$465K 0.07%
2,901
-86
-3% -$13.3K
ESGD icon
93
iShares ESG Aware MSCI EAFE ETF
ESGD
$12.2B
$462K 0.07%
4,864
-11
-0.2% -$1.04K
IWM icon
94
iShares Russell 2000 ETF
IWM
$81.5B
$447K 0.06%
1,815
SCHV
95
Schwab US Large-Cap Value ETF
SCHV
$16.1B
$414K 0.06%
13,976
-578
-4% -$16.9K
NULG icon
96
Nuveen ESG Large-Cap Growth ETF
NULG
$2.76B
$407K 0.06%
4,157
-9
-0.2% -$889
JPM icon
97
JPMorgan Chase
JPM
$956B
$401K 0.06%
1,244
+11
+0.9% +$3.41K
AMGN icon
98
Amgen
AMGN
$226B
$400K 0.06%
1,221
+4
+0.3% +$1.27K
DIS icon
99
Walt Disney
DIS
$178B
$398K 0.06%
3,498
+82
+2% +$9.03K
HD icon
100
Home Depot
HD
$350B
$397K 0.06%
1,154
-18
-2% -$6.59K

Similar funds

Kelman-Lazarov Inc's Q4 2025 Portfolio in Review

As of Q4 2025, Kelman-Lazarov Inc held 137 positions worth $700M, up 3.8% from $674M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Kelman-Lazarov Inc's Q4 2025 filing shows 5 new, 78 increased, 36 reduced and 3 closed positions. Its largest new stake was State Street Technology Select Sector SPDR ETF: 2,182 shares worth $314K. The largest sale was Goldman Sachs ActiveBeta International Equity ETF, an estimated $19.4M.

By sector, the portfolio is most concentrated in Financials at 3.2% of assets, down from 3.3% a quarter earlier, followed by Technology and Communication Services.

  • Kelman-Lazarov Inc's largest Q4 2025 buy was State Street Technology Select Sector SPDR ETF: 2,182 shares worth $314K.
  • Kelman-Lazarov Inc added most to Avantis International Equity ETF in Q4 2025, an estimated $19.6M increase.
  • Kelman-Lazarov Inc's biggest Q4 2025 reduction was Goldman Sachs ActiveBeta International Equity ETF, cutting an estimated $19.4M.
  • Kelman-Lazarov Inc fully exited Schwab US REIT ETF in Q4 2025, selling an estimated $291K.
  • Kelman-Lazarov Inc's ten largest holdings make up 54% of its $700M portfolio in Q4 2025.
  • Kelman-Lazarov Inc opened 5 new positions and closed 3 in Q4 2025.
  • Kelman-Lazarov Inc's portfolio value rose 3.8% quarter-over-quarter to $700M.

Based on Kelman-Lazarov Inc's 13F filing for Q4 2025, filed 26 Jan 2026.